Artiva Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Artiva Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q3 2024.
  • Artiva Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $14.4M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14.4M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $15.1M Jun 30, 2024 10-Q 2024-08-29
Q4 2023 $16.5M Dec 31, 2023 10-Q 2024-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.